XPC expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.28799999999474E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.758180E-03 |
Normal-vs-Stage2 |
2.801600E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.181330E-03 |
Stage1-vs-Stage2 |
6.809800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.896800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.982600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.199100E-04 |
Normal-vs-AfricanAmerican |
1.71472999999089E-05 |
Normal-vs-Asian |
6.556800E-04 |
Caucasian-vs-AfricanAmerican |
1.418040E-03 |
Caucasian-vs-Asian |
3.455000E-01 |
AfricanAmerican-vs-Asian |
4.145700E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.485650E-02 |
Normal-vs-Female |
2.30399999999742E-05 |
Male-vs-Female |
4.756400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.202700E-03 |
Normal-vs-Extreme_Weight |
2.860700E-03 |
Normal-vs-Obese |
2.810300E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.979000E-01 |
Normal_Weight-vs-Obese |
5.727000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.223200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.116770E-03 |
Normal-vs-Age(41-60Yrs) |
1.239150E-03 |
Normal-vs-Age(61-80Yrs) |
8.198200E-04 |
Normal-vs-Age(81-100Yrs) |
9.920800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.232800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.105000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.151000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.789600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.412800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.128600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
1.474190E-01 |
Normal-vs-Grade 3 |
2.887800E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.967200E-01 |
Grade 2-vs-Grade 4 |
1.474190E-01 |
Grade 3-vs-Grade 4 |
2.887800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.792300E-04 |
Normal-vs-N1 |
6.07759999999846E-05 |
N0-vs-N1 |
2.313000E-01 |
|
|